Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 30,277Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 4NanoAlvand

02 6Incyte Corporation

03 5Medichem S.A

04 18Novartis Pharmaceuticals Australia Pty Limited

05 4Novartis Pharmaceuticals Corporation

06 3Novartis South Africa (Pty) Ltd

07 3ORIFARM GROUP AS

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothNanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.

Regulatory Info :

Registration Country : Iran

Ruxolitinib Phosphate

Brand Name : Relata

Dosage Form : Tablet

Dosage Strength : 5MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Iran

NanoAlvand

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothNanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.

Regulatory Info :

Registration Country : Iran

Ruxolitinib Phosphate

Brand Name : Relata

Dosage Form : Tablet

Dosage Strength : 10MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Iran

NanoAlvand

03

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothNanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.

Regulatory Info :

Registration Country : Iran

Ruxolitinib Phosphate

Brand Name : Relata

Dosage Form : Tablet

Dosage Strength : 15MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Iran

NanoAlvand

04

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothNanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.

Regulatory Info :

Registration Country : Iran

Ruxolitinib Phosphate

Brand Name : Relata

Dosage Form : Tablet

Dosage Strength : 20MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Iran

NanoAlvand

05

Iran Expo
Not Confirmed
arrow
arrow
Iran Expo
Not Confirmed

RUXOLITINIB PHOSPHATE

Brand Name : JAKAFI

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 5MG BASE

Packaging :

Approval Date : 2011-11-16

Application Number : 202192

Regulatory Info : RX

Registration Country : USA

blank

06

Iran Expo
Not Confirmed
arrow
arrow
Iran Expo
Not Confirmed

RUXOLITINIB PHOSPHATE

Brand Name : JAKAFI

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 10MG BASE

Packaging :

Approval Date : 2011-11-16

Application Number : 202192

Regulatory Info : RX

Registration Country : USA

blank

07

Iran Expo
Not Confirmed
arrow
arrow
Iran Expo
Not Confirmed

RUXOLITINIB PHOSPHATE

Brand Name : JAKAFI

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 15MG BASE

Packaging :

Approval Date : 2011-11-16

Application Number : 202192

Regulatory Info : RX

Registration Country : USA

blank

08

Iran Expo
Not Confirmed
arrow
arrow
Iran Expo
Not Confirmed

RUXOLITINIB PHOSPHATE

Brand Name : JAKAFI

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 20MG BASE

Packaging :

Approval Date : 2011-11-16

Application Number : 202192

Regulatory Info : RX

Registration Country : USA

blank

09

Iran Expo
Not Confirmed
arrow
arrow
Iran Expo
Not Confirmed

RUXOLITINIB PHOSPHATE

Brand Name : JAKAFI

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 25MG BASE

Packaging :

Approval Date : 2011-11-16

Application Number : 202192

Regulatory Info : RX

Registration Country : USA

blank

10

Iran Expo
Not Confirmed
arrow
arrow
Iran Expo
Not Confirmed

RUXOLITINIB PHOSPHATE

Brand Name : OPZELURA

Dosage Form : CREAM;TOPICAL

Dosage Strength : EQ 1.5% BASE

Packaging :

Approval Date : 2021-09-21

Application Number : 215309

Regulatory Info : RX

Registration Country : USA

blank

16

Iran Expo
Not Confirmed
arrow
arrow
Iran Expo
Not Confirmed

Ruxolitinib

Brand Name : Jakavi

Dosage Form : Tablet

Dosage Strength : 10mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

17

Iran Expo
Not Confirmed
arrow
arrow
Iran Expo
Not Confirmed

Ruxolitinib

Brand Name : Jakavi

Dosage Form : Tablet

Dosage Strength : 15mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

18

Iran Expo
Not Confirmed
arrow
arrow
Iran Expo
Not Confirmed

Ruxolitinib Phosphate

Brand Name : Jakavi

Dosage Form : Antic-calc Tablet

Dosage Strength : 15 mg

Packaging : Blister

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

19

Iran Expo
Not Confirmed
arrow
arrow
Iran Expo
Not Confirmed

Ruxolitinib Phosphate

Brand Name : Jakavi

Dosage Form : Antic-calc Tablet

Dosage Strength : 20 mg

Packaging : Blister

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

20

Iran Expo
Not Confirmed
arrow
arrow
Iran Expo
Not Confirmed

Ruxolitinib Phosphate

Brand Name : Jakavi

Dosage Form : Antic-calc Tablet

Dosage Strength : 5 mg

Packaging : Blister

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank